Inventor
Ann BRIGÉ
Inventor
BE
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides38%
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
PatentTitleYear
12,528,860Polypeptides comprising immunoglobulin single variable domains targeting TNFa and IL-23202612,522,652Method for the production of immunoglobulin single variable domains202612,509,522Polypeptides comprising immunoglobulin single variable domains targeting il-13 and OX40L202512,492,239Antigen binding dimer-complexes, methods of making/avoiding and uses thereof202512,492,248Methods of treatment utilizing polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP202512,384,840Nucleic acids encoding polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP202511,897,951Polypeptides comprising immunoglobulin single variable domains targeting IL-6 and TNF-a202411,840,566Methods of treating asthma with polypeptides targeting IL-13 and TSLP202311,332,525Polypeptides comprising immunoglobulin single variable domains targeting TNFA and IL-23202211,208,476Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to ABLYNX NV (10)· patent assignee history
2021–2026Patents assigned to SANOFI SA (8)· patent assignee history
2021–2026Based in BE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABLYNX NV | 10 | 2021–2026 |
| SANOFI SA | 8 | 2021–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| BE | 10 | 2021–2026 |